Brief: Spanish Regulator Grants Enlivex Authorization To Expand Its Phase IIB Trial Evaluating Allocetra
10/11/2021 14:22
Nov 10 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* SPANISH REGULATOR GRANTS ENLIVEX AUTHORIZATION TO EXPAND
ITS
PHASE IIB TRIAL EVALUATING ALLOCETRA IN SEVERE AND CRITICAL
COVID-19 PATIENTS INTO SPAIN
Source text for Eikon: ID:nGNX4FHKM
Further company coverage: ENLV.TA
Recent news on Enlivex
See all newsBrief: Enlivex Announces 1-For-16 Reverse Share Split To Be Effective October 27, 2026
Brief: Enlivex Announces $400,000,000 Private Placement
Brief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares